Skip to Main Content

Author Details

Jalna Meens
Princess Margaret Cancer Centre, University Health Network
2004
25
15
PMIDPaper TitleJournal TitlePublished Year
35238880Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.JAMA Otolaryngol Head Neck Surg2022
34813980Side population analysis in clear cell renal cell carcinoma.Biochem Biophys Res Commun2021
34383182Dose predictions for [<sup>177</sup>Lu]Lu-DOTA-panitumumab F(ab')<sub>2</sub> in NRG mice with HNSCC patient-derived tumour xenografts based on [<sup>64</sup>Cu]Cu-DOTA-panitumumab F(ab')<sub>2</sub> - implications for a PET theranostic strategy.EJNMMI Radiopharm Chem2021
32434219Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.J Exp Med2020
31969334PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2020
31864959Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.Oral Oncol2020
33059733TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.J Exp Clin Cancer Res2020
33111077Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma.STAR Protoc2020
32970704Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.PLoS One2020
30468243A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth.Int J Cancer2019
30380421Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.Cell Rep2018
28862278Correction: Rapid determination of the tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): a proof-of-concept demonstration.Analyst2017
28799592Rapid determination of the tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): a proof-of-concept demonstration.Analyst2017
27121191Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma.Sci Rep2016
25174397CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.Oncogene2015
25784716Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis.Mol Cancer Res2015
25823823CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis.Oncotarget2015
24718734Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction.Mol Cell Biochem2014
25547174Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.Breast Cancer Res2014
22824798Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis.Oncogene2013
23699534Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.Mol Cancer Res2013
19533669Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.J Cell Biochem2009
18316596A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.Cancer Res2008
15987432The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.Breast Cancer Res2005
14729052Disruption of Ca2+-dependent cell-matrix adhesion enhances c-Src kinase activity, but causes dissociation of the c-Src/FAK complex and dephosphorylation of tyrosine-577 of FAK in carcinoma cells.Exp Cell Res2004
  • 1 - 25 of 25

Recommended Authors

Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 0
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 17
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 2
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Pinaki Bose
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 13
Stephen B Keysar
University of Colorado Denver
Career Start Year 2006
Number of shared co-authors 0
Neil E Bhola
Zai Lab (US) LLC
Career Start Year 2006
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Joshua C Anderson
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 1
Ming Li
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 4
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 0
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2002
Number of shared co-authors 0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 5
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Mark M Moasser
Helen Diller Family Comprehensive Cancer Center
Career Start Year 1994
Number of shared co-authors 1
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 1993
Number of shared co-authors 0
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 2
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 15

Collaborators

Laurie Ailles
University of Toronto
Co-authored papers 14
Anthony C Nichols
University of Western Ontario
Co-authored papers 5
Kara M Ruicci
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 4
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 4
Nicole Pinto
School of Public Policy at the University of Calgary
Co-authored papers 4
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 4
Joe S Mymryk
University of Western Ontario
Co-authored papers 4
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 4
Paul C Boutros
University of California los angeles
Co-authored papers 4
John W Barrett
University of Western Ontario
Co-authored papers 4
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 2
William Stecho
University of Western Ontario
Co-authored papers 2
Alessandro Datti
University of Perugia
Co-authored papers 2
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 2
Farhad Ghasemi
Western University
Co-authored papers 2
Ren X Sun
Ontario Institute for Cancer Research, University of Toronto
Co-authored papers 2
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 2
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Co-authored papers 2
Christopher J Howlett
Western University
Co-authored papers 2
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Mushfiq H Shaikh
University of Western Ontario
Co-authored papers 1
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Neil Mundi
Southern Illinois University School of Medicine
Co-authored papers 1
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Co-authored papers 1
Krupal B Patel
Moffitt Cancer Center
Co-authored papers 1
Neil E Fleshner
University of Toronto
Co-authored papers 1
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 1
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Paul Plantinga
University of Western Ontario
Co-authored papers 1
Blaise A Clarke
University of Toronto.
Co-authored papers 1
Release 1.2